Alpha Biopharma
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
no.1089 Dong Daming Rd, Shanghai, Shangh...Phone Number
+86 2163862192Website
www.alphabiopharma.comRevenue
$19.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Alpha Biopharma
晨泰医药 is a global pharmaceutical company focused on the development and commercialization of innovative drugs, particularly in the field of oncology. The company has received support from several well-known domestic and international investment funds and is dedicated to creating urgently needed therapeutic medications. Their flagship product, Zolertinib, is a next-generation EGFR TKI drug designed for the treatment of advanced non-small cell lung cancer with CNS metastasis. With a commitment to patient-centered care, the company is actively involved in clinical research and has a robust pipeline of both marketed and investigational products.Explore more
Alpha Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alpha Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Alpha Biopharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Alpha Biopharma has new funding data
Website visits: Recent activity has been detected on your website
Check out if Alpha Biopharma is spiking on competitors!
Earning: See what the market has to say on Alpha Biopharma recently announced quarterly report
Alpha Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Alpha Biopharma launches new products
Click to see if Alpha Biopharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Alpha Biopharma
Recommended Actions
Find VP level buyers at Alpha Biopharma
Find 3 more new buyers
Company Profile Activity
Activity Insights
Alpha Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alpha Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alpha Biopharma.
Alpha Biopharma Tech Stack
A closer look at the technologies used by Alpha Biopharma
See more technologies
Alpha Biopharma News & Media
Alpha Biopharma Announces Completion of its EVEREST Phase II/III Clinical Study of Zorifertinib in Non-Small Cell Lung Cancer Patients with Central Nervous System Metastases
Zorifertinib is a next generation EGFR-TKI with full Blood Brain Barrier penetration targeting EGFRm+ NSCLC patients with CNS metastases Top-line data from the study are expected around the end of 2022 SHANGHAI, Aug. 24, 2022 /PRNewswire/ -- Alpha Biopharma, a developer of innovative...Wugen Announces Exclusive Partnership Agreement With Alpha Biopharma in Asia For Cell Therapies to Treat Cancer
ST. LOUIS, March 8, 2021 /PRNewswire/ -- Wugen Inc., a clinical-stage biotechnology company developing novel universal natural killer (NK) and T-cell therapies for the treatment of cancer, today announced that it has entered into an exclusive license and collaboration agreement with Shanghai-based Alpha Biopharma Inc. to manufacture, develop, and commercialize its allogeneic cell products in Asia, including mainland China, Hong Kong, Macao, Taiwan region and Singapore. The products included in t
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alpha Biopharma
Sign Up For FreeTo access detailed company insights
晨泰医药 is a global pharmaceutical company focused on the development and commercialization of innovative drugs, particularly in the field of oncology. The company has received support from several well-known domestic and international investment funds and is dedicated to creating urgently needed therapeutic medications. Their flagship product, Zolert... Read More
